Colin Brooks

Tumour cells in metastatic deposits with altered sensitivity to natural killer cells

R. W. Baldwin, S. Kenwrick, N. Willmott, 1981, International journal of cancer.

MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells

T. Buchholz, R. Meyn, K. Mason, 2011, Clinical Cancer Research.

Gefitinib Radiosensitizes Non–Small Cell Lung Cancer Cells by Suppressing Cellular DNA Repair Capacity

Anupama Munshi, R. Meyn, A. Munshi, 2008, Clinical Cancer Research.

Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer

D. Kuban, R. Meyn, K. Mason, 2012, Radiation oncology.

The influence of deprivation and ethnicity on the incidence of esophageal cancer in England

N. Trudgill, C. Thomson, S. Cooper, 2009, Cancer Causes & Control.

Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer

D. Kuban, R. Meyn, K. Mason, 2012, Radiation oncology.

Cancer Therapy : Preclinical MK-1775 , a Novel Wee 1 Kinase Inhibitor , Radiosensitizes p 53-Defective Human Tumor Cells

T. Buchholz, R. Meyn, K. Mason, 2011 .